A phase Ib study of pembrolizumab (Pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver metastatic colorectal cancer (CRC).

被引：1

作者：

Turk, Anita Ahmed

Lubner, Sam Joseph

Uboha, Nataliya Volodymyrivna

LoConte, Noelle K.

Mulkerin, Daniel

Kim, David H.

Matkowskyj, Kristina

Weber, Sharon M.

Abbott, Daniel

Eickhoff, Jens C.

Bassetti, Michael F.

Deming, Dustin A.

机构：

[1] Indiana Univ, Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46204 USA

[2] Univ Wisconsin, Madison, WI USA

[3] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[4] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA

[5] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA

[6] Univ Wisconsin, Dept Human Oncol, Madison, WI USA

来源：

关键词：

D O I：

10.1200/JCO.2019.37.4_suppl.680

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

680

引用

页数：2